Inicio>>Signaling Pathways>> TGF-β / Smad Signaling>> PKC>>Phorbol 12,13-dibutyrate

Phorbol 12,13-dibutyrate (Synonyms: PDBu)

Catalog No.GC17352

El 12,13-dibutirato de forbol (dibutirato de forbol) es un activador de PKC y un potente promotor de tumores cutÁneos.

Products are for research use only. Not for human use. We do not sell to patients.

Phorbol 12,13-dibutyrate Chemical Structure

Cas No.: 37558-16-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
239,00 $
Disponible
1mg
72,00 $
Disponible
5mg
216,00 $
Disponible
10mg
360,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Phorbol 12,13-dibutyrate (Phorbol dibutyrate) is a PKC activator and a potent skin tumor promoter[1][2].

Phorbol 12,13-dibutyrate (Phorbol dibutyrate) (1 MM) activates PKC and inhibited Na/K-ATPase transport activity in OK cells[3].

References:
[1]. Singh J, et al. Immunocytochemical evidence for PDBu-induced activation of RhoA/ROCK in human internal anal sphincter smooth muscle cells. Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G317-25.
[2]. Szallasi Z, et al. Dissociation of phorbol esters leads to immediate redistribution to the cytosol of protein kinases C alpha and C delta in mouse keratinocytes. J Biol Chem. 1994 Nov 4;269(44):27159-62.
[3]. Middleton JP, et al. Heterogeneity of protein kinase C-mediated rapid regulation of Na/K-ATPase in kidney epithelial cells. J Biol Chem. 1993 Jul 25;268(21):15958-64.

Reseñas

Review for Phorbol 12,13-dibutyrate

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Phorbol 12,13-dibutyrate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.